Paradigm Biocapital Advisors LP Acrivon Therapeutics, Inc. Call Options Transaction History
Paradigm Biocapital Advisors LP
- $2.14 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding ACRV
# of Institutions
53Shares Held
18.5MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA8.34MShares$00.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA2.12MShares$00.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.9MShares$00.0% of portfolio
-
Wellington Management Group LLP Boston, MA888KShares$00.0% of portfolio
-
Black Rock Inc. New York, NY767KShares$00.0% of portfolio